[Congressional Record Volume 168, Number 201 (Friday, December 23, 2022)]
[Extensions of Remarks]
[Page E1357]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




    CHILDHOOD CANCER SURVIVORSHIP, TREATMENT, ACCESS, AND RESEARCH 
                      REAUTHORIZATION ACT OF 2022

                                 ______
                                 

                               speech of

                           HON. ANNA G. ESHOO

                             of california

                    in the house of representatives

                      Thursday, December 22, 2022

  Mr. ESHOO. Madam Speaker, I rise in support of S. 4120, the Childhood 
Cancer STAR Reauthorization Act. As Chairwoman of the House Health 
Subcommittee, I'm proud to have advanced this bipartisan bill and I'm 
pleased to support it on the Floor today.
  I thank Representatives Speier, Butterfield, and McCaul for their 
work on this important bill. I especially would like to recognize 
Representatives Speier and Butterfield for their longstanding 
dedication to helping children with cancer and to congratulate them on 
passing this vital bill on their last days of service in the Congress.
  Every day families face the nightmare of a child diagnosed with 
cancer. Nearly 10,500 children in the U.S. under the age of 15 were 
diagnosed with cancer in 2022. Today we're delivering hope for those 
families.
  The Childhood Cancer Survivorship, Treatment, Access, and Research 
(STAR) Act is the most comprehensive childhood cancer bill ever passed 
into law. Since it was signed into law in 2018, the STAR Act has helped 
deliver over $120 million to fund childhood cancer research and assist 
patients and families battling cancer. It expands opportunities for 
childhood cancer research at the National Cancer Institute, improves 
efforts to track pediatric cancer incidences, and, importantly, 
enhances the quality of life for childhood cancer survivors.
  Today's legislation is a simple reauthorization of these life-saving 
programs to ensure there is no lapse in funding or disruption in 
important research. Today, the Democratic House is delivering for the 
children and I urge my colleagues to support this important bill.